We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus) (REMOTE-COVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04337489
Recruitment Status : Completed
First Posted : April 7, 2020
Last Update Posted : February 24, 2022
CW+ Charity
Information provided by (Responsible Party):
Imperial College London

Brief Summary:
The study aims to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If sick patients can be identified early, participants are more likely to have better outcomes; the study believes that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.

Condition or disease Intervention/treatment
Coronavirus Device: SensiumVitals wearable sensor

Layout table for study information
Study Type : Observational
Actual Enrollment : 14 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial
Actual Study Start Date : July 28, 2020
Actual Primary Completion Date : March 26, 2021
Actual Study Completion Date : March 26, 2021

Resource links provided by the National Library of Medicine

Intervention Details:
  • Device: SensiumVitals wearable sensor
    A waterproof, light, wearable sensor measuring vital signs (heart rate, respiratory rate, temperature) continuously.

Primary Outcome Measures :
  1. Deterioration resulting in healthcare review [ Time Frame: 1 year ]
    Detection of clinical deterioration using wearable sensors resulting in healthcare review (e.g. GP telephone consultation)

Secondary Outcome Measures :
  1. Hospitalisation [ Time Frame: 1 year ]
    Deterioration resulting in hospitalisation

  2. Participant anxiety [ Time Frame: 1 year ]
    General Anxiety Disorder (GAD-7) questionnaire (responses noted on Likert scales); min score 0 and max score 21. Higher score associated with greater anxiety

  3. Participant depression [ Time Frame: 1 year ]
    Patient Health Questionnaire (PHQ-9) questionnaire (responses noted on Likert scales); min score 0 and max score 27. Higher score associated with greater depression.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 95 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  • Returning traveller from a high-risk area into a London airport.
  • Have mild symptoms indicative of Covid-19
  • Unable to self-isolate

Inclusion Criteria:

  • Aged 18 years or over.
  • Able to provide written consent.

Exclusion Criteria:

  • Any participants that withdraw their consent.
  • A skin condition/reaction preventing wearing the wearable sensor.
  • The presence of a permanent pacemaker or cardiac defibrillator.
  • Any form of psychiatric disorder or a condition that, in the opinion of the investigator, may hinder communication with the research team.
  • Inability to cooperate or communicate with the research team.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04337489

Layout table for location information
United Kingdom
Imperial College London
London, United Kingdom
Sponsors and Collaborators
Imperial College London
CW+ Charity
Layout table for investigator information
Principal Investigator: Ara Darzi, Prof Institute of Global Health Innovation
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Imperial College London
ClinicalTrials.gov Identifier: NCT04337489    
Other Study ID Numbers: REMOTE-COVID
First Posted: April 7, 2020    Key Record Dates
Last Update Posted: February 24, 2022
Last Verified: February 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Keywords provided by Imperial College London:
remote monitoring
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Virus Diseases